73 related articles for article (PubMed ID: 22362121)
1. The prognostic role of hemochromatosis H63D allele in allogeneic hematopoietic stem cell transplantation.
Sucak GT; Yaşar DG; Yegin ZA; Ergün MA; Ozkurt ZN; Aki ŞZ; Güntekin S
Ann Hematol; 2012 Aug; 91(8):1281-7. PubMed ID: 22362121
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L
Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086
[TBL] [Abstract][Full Text] [Related]
3. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of H63D, S65C, and C282Y hereditary hemochromatosis gene variants in Madeira Island (Portugal).
Spínola C; Brehm A; Spínola H
Ann Hematol; 2011 Jan; 90(1):29-32. PubMed ID: 20714725
[TBL] [Abstract][Full Text] [Related]
5. Relation between HFE mutations and mild iron-overload expression.
Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.
Simsek H; Balaban YH; Yilmaz E; Sumer H; Buyukasik Y; Cengiz C; Ozcebe O; Hascelik G; Tatar G
Ann Hematol; 2005 Oct; 84(10):646-9. PubMed ID: 15871018
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of HFE mutations among the Thai population and correlation with iron loading in haemoglobin E disorder.
Viprakasit V; Vathesathokit P; Chinchang W; Tachavanich K; Pung-Amritt P; Wimhurst VL; Yenchitsomanus PT; Merryweather-Clarke AT; Tanphaichitr VS
Eur J Haematol; 2004 Jul; 73(1):43-9. PubMed ID: 15182337
[TBL] [Abstract][Full Text] [Related]
8. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
[TBL] [Abstract][Full Text] [Related]
9. Frequency and clinical expression of HFE gene mutations in a Spanish population of subjects with abnormal iron metabolism.
Gómez-Llorente C; Miranda-León MT; Blanco S; Gandia-Pla S; Gómez-Capilla JA; Fárez-Vidal ME
Ann Hematol; 2005 Oct; 84(10):650-5. PubMed ID: 15986199
[TBL] [Abstract][Full Text] [Related]
10. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
[TBL] [Abstract][Full Text] [Related]
11. The influence of hemochromatosis mutations on iron overload of thalassemia major.
Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
[TBL] [Abstract][Full Text] [Related]
12. Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes.
Milman N; Pedersen P; Ovesen L; Melsen GV; Fenger K
Ann Hematol; 2004 Oct; 83(10):654-7. PubMed ID: 15141324
[TBL] [Abstract][Full Text] [Related]
13. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
[TBL] [Abstract][Full Text] [Related]
14. Genetics of hemochromatosis.
Cullen LM; Anderson GJ; Ramm GA; Jazwinska EC; Powell LW
Annu Rev Med; 1999; 50():87-98. PubMed ID: 10073265
[TBL] [Abstract][Full Text] [Related]
15. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.
Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G
Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
[TBL] [Abstract][Full Text] [Related]
17. Iron overload in kidney transplants: prospective analysis of biochemical and genetic markers.
Lorenz M; Kletzmayr J; Huber A; Hörl WH; Sunder-Plassmann G; Födinger M
Kidney Int; 2005 Feb; 67(2):691-7. PubMed ID: 15673318
[TBL] [Abstract][Full Text] [Related]
18. HFE gene C282Y, H63D and S65C mutations frequency in the Transylvania region, Romania.
Trifa AP; Popp RA; Militaru MS; Farcaş MF; Crişan TO; Gana I; Cucuianu A; Pop IV
J Gastrointestin Liver Dis; 2012 Jun; 21(2):177-80. PubMed ID: 22720307
[TBL] [Abstract][Full Text] [Related]
19. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload.
De Gobbi M; Daraio F; Oberkanins C; Moritz A; Kury F; Fiorelli G; Camaschella C
Haematologica; 2003 Apr; 88(4):396-401. PubMed ID: 12681966
[TBL] [Abstract][Full Text] [Related]
20. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.
Barton JC; Lee PL; West C; Bottomley SS
Am J Hematol; 2006 Oct; 81(10):760-7. PubMed ID: 16838333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
